EXAS logo

Combined Holdings of EXAS in All ARK ETFs

Exact Sciences Corp.

Exact Sciences Corporation is a molecular diagnostics company specializing in the detection and prevention of certain types of cancer. The company makes money by developing and selling non-invasive screening tests, such as Cologuard, for early cancer detection, primarily generating revenue through product sales and service agreements with healthcare providers.

Trades of EXAS in All Ark ETFs

The ten most recent trades of Exact Sciences Corp. in all the Ark ETFs ETF.View all trades

Date
Direction
Market Value
% of Position
% of ETF
Nov 20, 2024Sell$486,73710.40%0.04%
Nov 18, 2024Sell$1,151,54920.90%0.10%
Nov 13, 2024Sell$2,040,84826.50%0.16%
Nov 12, 2024Sell$2,472,97524.77%0.18%
Sep 11, 2024Sell$953,4677.14%0.07%
Aug 07, 2024Sell$2,574,95017.37%0.19%
Jul 01, 2024Sell$20,1581.33%0.00%
Jun 27, 2024Sell$623,42639.14%0.01%
Jun 20, 2024Sell$7,000,7688.16%0.52%
Jun 10, 2024Sell$2,118,0617.76%0.03%